TransMedics (TMDX) Interest Expenses (2018 - 2026)

TransMedics' Interest Expenses history runs 9 years deep, the most recent figure standing at $374.6 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 10723.17% year-over-year to $374.6 million in Q1 2026; TTM through Mar 2026 was $374.6 million, a 3817.08% increase from a year earlier, with the FY2025 full-year figure at $199.7 million, up 159.84% from the prior year.
• Interest Expenses climbed to $374.6 million in Q1 2026 per TMDX's latest filing, from $7.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $374.6 million in Q1 2026 and bottomed at -$1.1 million in Q4 2024.
• The 5-year median for Interest Expenses is $3.5 million (2025), against an average of $24.2 million.
• Across the five-year window, Interest Expenses sank 200.51% in 2023 and soared 10723.17% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $981000.0 in 2022, then sank by 200.51% to -$986000.0 in 2023, then declined by 15.42% to -$1.1 million in 2024, then soared by 768.01% to $7.6 million in 2025, then surged by 4827.52% to $374.6 million in 2026.
• Per Business Quant, the three latest TMDX Interest Expenses figures stand at $374.6 million (Q1 2026), $7.6 million (Q4 2025), and $3.5 million (Q3 2025).